Amwill Healthcare’s shares will debut on the BSE SME platform with an IPO price of Rs 111 each. The IPO saw moderate investor interest, driven by institutional support. Amwill focuses on derma-cosmetic products, outsourcing manufacturing and distribution to third parties. India’s $14 billion beauty industry is growing rapidly due to online sales and a trend toward personalised products.
Sebi to revamp short-selling, securities lending rules
Sebi is reviewing short-selling and securities lending rules to improve liquidity and price discovery. The regulator is also planning reforms in clearing, broker compliance, custodial